ImmunoGen, Inc. (0A8K.L) LSE
31.24
+0.01(+0.03%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.04B |
| Enterprise Value | 815.93M |
| P/E Ratio | -35.54 |
| PEG Ratio | -0.52 |
| Price/Sales Ratio | 80.21 |
| Price/Book Ratio | 50.84 |
| Enterprise/Revenue | 77.82 |
| Enterprise/EBITDA | -39.24 |
Fiscal Year
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | September 30, 2023 |
Profitability
| Profit Margin | -2.05 |
| Operating Margin | -2.03 |
Management Effectiveness
| Return On Assets | -0.64 |
| Return On Equity | -0.93 |
Income Statement
| Revenue | 108.78M |
| Revenue/Share | 0.43 |
| Gross Profit | 106.82M |
| EBITDA | -219.11M |
| Net Income | -222.93M |
| Diluted EPS | -0.88 |
Balance Sheet
| Total Cash | 605.54M |
| Total Cash/Share | 1.08 |
| Total Debt | 110.22M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 2.26 |
| Book Value Per Share | 0.61 |
Price History
| 52-Week Change | 746.15 |
| 52-Week High | 31.25 |
| 52-Week Low | 31.24 |
| Moving Average 50 Days | 29.05 |
| Moving Average 200 Days | 18.86 |
Statistics
| Average Volume | 23,479 |
| Shares Outstanding | 264.47M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
